Decreased Acetic Acid in the Stool of Preterm Infants Is Associated with an Increased Risk of Bronchopulmonary

Lauren C Frazer1, William Yakah2, Camilia R Martin3

  • 1Department of Pediatrics, Division of Neonatal-Perinatal Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Nutrients
|June 24, 2022
PubMed

Insights

Low levels of acetic acid in preterm infants' stool are linked to a higher risk of bronchopulmonary disease (BPD). This suggests a connection between gut health and lung development in premature babies.

Area of Science:

  • Neonatal pathophysiology
  • Microbiome research
  • Gastroenterology and Pulmonology

Background:

  • Short-chain fatty acids (SCFAs), microbial metabolites, are understudied in neonatal diseases but linked to adult outcomes.
  • Investigating SCFA levels in maternal breastmilk and preterm infant stool is crucial for understanding neonatal morbidities.
  • Preterm infants (< 28 weeks gestation) are a vulnerable population requiring focused research on factors influencing their health.

Purpose of the Study:

  • To determine if SCFA levels in maternal breastmilk (BM) and preterm infant stool correlate with neonatal morbidities.
  • To assess the impact of specific SCFAs, particularly acetic acid, on the risk of bronchopulmonary disease (BPD) and retinopathy of prematurity (ROP).
  • To explore the relationship between gut microbiome metabolites and the development of common neonatal complications.

Main Methods:

  • Quantification of SCFA levels using liquid chromatography with tandem mass spectrometry.
  • Analysis of maternal BM and preterm infant stool samples (N=72) at postnatal days 14 and 28.
  • Comparison of SCFA levels in infants with and without BPD and ROP, employing logistic regression for association analysis.

Main Results:

  • SCFA levels, including acetic, propionic, and others, showed an increase in BM and infant stool from day 14 to 28.
  • A significant inverse relationship was found between fecal acetic acid levels and the odds of developing BPD.
  • Each quartile increase in fecal acetic acid was associated with reduced odds of BPD (OR 0.41 on day 14, 0.28 on day 28), but not ROP.

Conclusions:

  • Lower levels of acetic acid in preterm infant stool are associated with increased odds of bronchopulmonary disease.
  • These findings highlight a potential link between intestinal health, indicated by SCFA profiles, and pulmonary outcomes in preterm neonates.
  • The study supports the hypothesis that gut microbiome-derived metabolites play a role in neonatal health and disease development.

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
311
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
60.3K
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
431
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
503
Bronsted-Lowry Acids and Bases02:58

Bronsted-Lowry Acids and Bases

The acid-base reaction class has been studied for quite some time. In 1680, Robert Boyle reported traits of acid solutions that included their ability to dissolve many substances, to change the colors of certain natural dyes, and to lose these traits after coming in contact with alkali (base) solutions. In the eighteenth century, it was recognized that acids have a sour taste, react with limestone to liberate a gaseous substance (now known to be CO2), and interact with alkalis to form neutral...
93.7K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
421